Continuous Glucose Monitoring in Neonatal Hyperinsulinism

Description

The investigators are studying the accuracy of Dexcom G6 continuous glucose monitors placed on babies with hyperinsulinism in the Miller Children's Hospital Neonatal Intensive Care Unit. The participants will wear the device for 10 days on their lateral thigh. Whenever blood sugars are checked by glucometer, the investigators will also record the continuous glucose monitor sugar. Additionally, if the continuous glucose monitor alarms for a low sugar or an impending low sugar, the investigators will check the blood sugar by glucometer and, if verified to be low, treat the low blood sugar accordingly.

Conditions

Hyperinsulinism, Hypoglycemia Neonatal

Talk to us

Study Overview

On this page

Study Details

Study overview

The investigators are studying the accuracy of Dexcom G6 continuous glucose monitors placed on babies with hyperinsulinism in the Miller Children's Hospital Neonatal Intensive Care Unit. The participants will wear the device for 10 days on their lateral thigh. Whenever blood sugars are checked by glucometer, the investigators will also record the continuous glucose monitor sugar. Additionally, if the continuous glucose monitor alarms for a low sugar or an impending low sugar, the investigators will check the blood sugar by glucometer and, if verified to be low, treat the low blood sugar accordingly.

A Study to Evaluate the Accuracy of Continuous Glucose Monitors in Neonates With Hyperinsulinism.

Continuous Glucose Monitoring in Neonatal Hyperinsulinism

Condition
Hyperinsulinism
Intervention / Treatment

-

Contacts and Locations

Long Beach

Miller Children's Hospital, Long Beach, California, United States, 90806

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age: 0-90 days old
  • * Gestational Age: \> 28 weeks gestational age
  • * Diagnosis of hyperinsulinism based on critical sample and/or glucagon challenge
  • * Diffuse skin disease such that placement of a Dexcom G6 sensor would be difficult to secure
  • * Infants colonized or infected with multi-drug resistant organisms (i.e. MRSA, VRE, ESBL producing bacteria)
  • * Infants on hypothermic protocols
  • * Infants expected to remain in the NICU \<24 hours
  • * Infants enrolled in a competing clinical trial
  • * Family/team have decided to limit or redirect from aggressive NICU technological support
  • * Ward of the state

Ages Eligible for Study

24 Hours to 3 Months

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

MemorialCare Health System,

Study Record Dates

2025-12-31